More than 14 million people are battling cancer in the United States today. That number is said to rise to abound 19 million by the year 2024, according to the National Cancer Institute. Great strides have been made in medical and cancer research, but still there was much more to be done. After experiencing the heart breaking breast cancer that his wife was diagnosed with, Eric Lefkofsky wanted to establish a means of bringing cancer diagnosis and treatment into the twenty first century. Eric co-founded Tempus, which is a company that has made many advances and has taken the lead in data of precision medicine that is data enabled. The health care industry was lagging behind in modern technology, and had not developed the use of electronic health records. Doctors were still using hand written notes that were not always easily accessible. He found that data collection and digital technology were not effectively combined. The goal of Tempus was to make a transformation in the way that cancer care was delivered. It developed a platform that analyzed the molecular as well as the clinical data of the cancer patient.
Eric Lefkofsky, a co-founder of Tempus, is also the Chief Executive Officer. He is an entrepreneur and a philanthropist. In 2006, he and his family established the Lefkofsky Family Foundation, a private charitable organization who’s mission is to help enhance the quality of human life. He is a graduate of The University of Michigan, and received his Juris Doctorate from The University of Michigan Law School. Eric is also the published author of the book, Accelerated Disruption. With the co founding of the technology company Tempus, the world’s largest library of molecular and clinical data. doctors can now deliver a more personalized treatment and care for their cancer patients. Now patients can benefit from the treatment that has been done for others through a data base of pertinent clinical and molecular information.
Eric Lefkofsky info: www.tempus.com/about-us/